Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increase in number of heart failures and cardiovascular diseases
3.2.1.2 Technological advancements
3.2.1.3 Rise in awareness regarding heart failure treatment
3.2.1.4 Growing R&D expenditure
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.2.2.2 High cost of device and procedures
3.3 Growth potential analysis
3.4 Porter's analysis
3.5 PESTEL analysis
3.6 Future market trends
3.7 Reimbursement scenario
3.8 Regulatory landscape
3.9 Technological landscape
3.10 GAP analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Implanted heart pump devices
5.3 Extracorporeal heart pump devices
Chapter 6 Market Estimates and Forecast, By Device, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Ventricular assist devices (VADs)
6.2.1 Left ventricular assist devices (LVAD)
6.2.2 Right ventricular assist devices (RVAD)
6.2.3 Bi-ventricular assist devices (BiVAD)
6.2.4 Percutaneous ventricular assist devices (PVAD)
6.3 Total artificial hearts (TAHs)
6.4 Intra-aortic balloon pumps (IABPs)
6.5 Extracorporeal membrane oxygenation (ECMO)
Chapter 7 Market Estimates and Forecast, By Therapy, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Destination therapy
7.3 Bridge-to-candidacy (BTC) therapy
7.4 Bridge-to-transplant (BTT) therapy
7.5 Bridge-to-recovery (BTR) therapy
7.6 Other therapies
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Cardiac centers
8.4 Ambulatory surgical centers
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 ABIOMED
10.3 Berlin Heart
10.4 BiVACOR Inc.
10.5 CARMAT
10.6 CorWave SA
10.7 Evaheart, Inc.
10.8 Fresenius SE & Co. KGaA
10.9 Getinge AB
10.10 Jarvik Heart
10.11 Leviticus Cardio
10.12 LivaNova PLC
10.13 Medtronic plc
10.14 SynCardia Systems, LLC
10.15 Teleflex Incorporated
